Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
F&S Reports, 2023 I describe how we identified the need to block the luteinizing hormone (LH) surge when trying to control the processes of luteinization and ovulation within the clinic.
Richard Fleming, Ph.D.
doaj +2 more sources
Gonadotropin-releasing hormone analogs: Understanding advantages and limitations
Journal of Human Reproductive Sciences, 2014 Pituitary stimulation with pulsatile gonadotropin-releasing hormone (GnRH) analogs induces both follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
Pratap Kumar, Alok Sharma
doaj +2 more sources
Gonadotropin-Releasing Hormone: Physiological and Therapeutic Aspects, Agonists and Antagonists [PDF]
Hormone Research, 2008 Rapid advances in the understanding of gonadotropin-releasing hormone (GnRH) actions and in development of new agonist and antagonist analogues of GnRH have taken place over the past several years. As a result, new compounds are now available to treat patients with various disorders of reproductive function.
Santen, R.J., Bourguignon, Jean-Pierre
openaire +4 more sources
Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls [PDF]
International Journal of Endocrinology and Metabolism, 2015 Depot preparations of gonadotropin-releasing hormone agonists (GnRHa) are the gold standard drugs for the treatment of central precocious puberty. A concern about these drugs is obesity.This study aimed to investigate the effect of gonadotropin-releasing hormone agonists (GnRHa) therapy on body mass index (BMI) in girls with central precocious puberty (
Shiasi Arani, Kobra, Heidari, Fatemeh
openaire +3 more sources
Journal of Research in Medical Sciences, 2007 <p>Aggressive angiomyxoma is a rare soft tissue neoplasm that usually arises within the perineum. It often occurs as a vulvar mass and clinically simulates a Bartholin's gland cyst.
Azar Danesh, Mohammad Hossein Sanei
doaj +1 more source
Gonadotrophin releasing hormone agonist with low dose human chorionic gonadotrophin co-triggers versus gonadotrophin releasing hormone agonist alone for reducing the risk of ovarian hyperstimulation in women with polycystic ovarian disease. [PDF]
Al-Azhar International Medical Journal, 2022 Background: “Dual triggering” for final oocyte maturation using acombination of a gonadotropin-releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG) can improve clinical outcomes in high responders during in vitro fertilization ...
Mohamed Gebreel +3 more
doaj +1 more source
Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2021 Purpose There are few reports on the therapeutic effects of gonadotropin-releasing hormone agonists in boys with central precocious puberty, and studies reported in Korea are very rare.
Ah Young Cho +3 more
doaj +1 more source
Invitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg [PDF]
Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2020 Introduction: Human chorionic gonadotropin for the final maturation of eggs in the In-vitro fertilization cycle was associated with the possibility of a negative effect on endometrial acceptance, fetal quality and ovarian hyper stimulation syndrome ...
Alamtaj Samsami +5 more
doaj +1 more source
AJOG Global Reports, 2023 BACKGROUND: Recent studies have reported higher risks of adverse maternal and neonatal outcomes, such as hypertensive disorders of pregnancy, after programmed frozen embryo transfer, especially in cycles with gonadotropin-releasing hormone agonist ...
Hui-ying Jie, MD +6 more
doaj +1 more source
Luteal-phase support in assisted reproductive technology: An ongoing challenge
International Journal of Reproductive BioMedicine, 2021 It has been shown that in controlled ovarian hyper stimulation cycles, defective luteal phase is common. There are many protocols for improving pregnancy outcomes in women undergoing fresh and frozen in vitro fertilization cycles.
Saeideh Dashti, Maryam Eftekhar
doaj +1 more source